Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, today announced Medicare coverage of its ultrasensitive NeXT Personal® test for surveillance of cancer recurrence ...
The traditional model of one-time sales is giving way to continuous value delivery through software, altering how companies ...
Chaplin, J. , Akhtari, A. and Lum, W. (2025) Recurrent Deep Vein Thrombosis (DVT) with Negative D-Dimer in a Patient on Rivaroxaban: A Diagnostic Pitfall. Open Journal of Emergency Medicine, 13, ...
Key Points Immuron receives U.S. Food and Drug administration (FDA) approval for IMM-529 Investigational New Drug (IND) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback